Altimmune announces fda clearance of adcovid™ ind application

Enrollment in phase 1 clinical trial of single-dose, needle-free, intranasal covid-19 vaccine candidate set to begin in the coming week enrollment in phase 1 clinical trial of single-dose, needle-free, intranasal covid-19 vaccine candidate set to begin in the coming week
ALT Ratings Summary
ALT Quant Ranking